<analysis>
**Action 1 (hardening the alignment slice).** Checkpointing, a canary job and a batched per-run manifest are mundane engineering. Security accepting the batched sign-off is plausible, because it respects their per-run rule. The real risks are these:
- Security may want more than a 10-minute review.
- Mythos 5.2 elicitation reviewers may still be thin.
- Tamper-resistance is third priority and may only reach setup.

Four ordered priorities on a slice that has only just been repaired make partial success the likely result: (a) and (b) are reachable, while (c) and (d) are preliminary. If the elicitation finds something material, Threat 4 covers it; that risk is not counted here.

**Action 2 (post-listing ladder).** This requires pricing to actually happen in May, with base-case odds of about 85%. It then requires a decision meeting within 14 days during the research quiet period and before the first 10-Q. In April, leadership refused even a board-minute fallback. Rung 1 (a published gate) is cheap and was already drafted, so partial success means at least rung 1 or a dated revisit. Failure means no meeting, or a meeting with nothing recorded. The softened-outcome path belongs to Threat 1, so the two must not be double-counted.

**Action 3 (Wyden, AISI, EU).** These are routine attributed channels with existing contacts. Sending text to staff is easy. Whether the text gets adopted is not the test this month.

**Action 4 (Kit v2, monitor, playbook, bounty).** Shipping a classifier plus write-up is feasible within a month. The ETH co-sign is uncertain. A comms review during the IPO window can delay neutral score publication, though it matters less after pricing. The bounty relaunch depends on the listing. Weight-level hardening failure is Threat 2 and provider uptake is Threat 3, so neither is counted here.

**Action 5 (Transition Program, medical, protein).** Launching a new public program within about two weeks of listing needs sign-off from legal and comms, and verification design takes time. Accepting the DUA terms is plausible if retention fits policy, and the IRB submission is routine. Enrolment shortfall and press framing belong to Threat 5.

**Exogenous releases, rolled in message 2.**
- **Grok 5:** about 75% it ships in May, most likely closed-weight and roughly at the Gemini 4 level on agentic tasks.
- **Qwen 4:** about 70% it ships in May, with mid-size tiers open and the flagship likely API-only.

Both feed the capability index and IPO competitive pressure.
</analysis>

<action_odds>
Action 1 [Harden and refocus the alignment slice]: P(failure) 35%. Reason: The fixes are routine and the batched sign-off is plausible, but security may resist it. The slice has a recent failure history, and four priorities on 3% compute make partial success the modal outcome.

Action 2 [Post-listing commitment ladder]: P(failure) 50%. Reason: It needs pricing to happen, then a board meeting within 14 days during the quiet period and before the first 10-Q. Leadership refused a board-minute fallback in April. Rung 1 is cheap, which keeps success at even odds. Softened outcomes are modelled by Threat 1.

Action 3 [Wyden text, AISI support, EU follow-up]: P(failure) 20%. Reason: These are established attributed channels and staff asked for this text. Residual risk is counsel delay during the listing month and AISI June-pass logistics.

Action 4 [Kit v2, monitor, playbook, bounty]: P(failure) 40%. Reason: It has many components. The ETH co-sign is uncertain, and the comms review and bounty both depend on listing timing. Claude-run playbooks remove the Hugging Face bottleneck. Hardening efficacy and provider uptake are modelled separately.

Action 5 [Transition Program, DUA/IRB, protein memo]: P(failure) 45%. Reason: Launching a new public program within weeks of listing needs sign-off from legal, comms and verification design. The DUA acceptance and IRB submission are more routine. Enrolment and press risk are in Threat 5.
</action_odds>

<threat_odds>
Threat 1 [Board softens the ladder past August]: P(materialises) 55%. Adversary suggested 50%. It is slightly higher because leadership refused even a board-minute fallback in April. The first earnings call and fiduciary framing give the same instinct a new justification, and a pricing slip adds to it.

Threat 2 [Meta-learning hardening fails on record]: P(materialises) 50%. Adversary suggested 60%. The literature strongly supports this failure mode. However, workstream (c) is third priority on a repaired 3% slice, so a conclusive negative result published in May is less than certain.

Threat 3 [Providers refuse the per-request monitor]: P(materialises) 75%. Adversary suggested 65%. It is higher because the threat only requires no default deployment in May. That is the strong base case given latency, zero-data-retention promises, liability concerns and a one-month timeline.

Threat 4 [Mythos 5.2 elicitation forces a slip or override]: P(materialises) 35%. Adversary suggested 40%. The redo is designed to find more and cyber cases cluster there. However, a finding material enough to force a further slip or a logged override is less likely than a finding that simply refines the ceiling.

Threat 5 [Transition Program misses workers or reads as PR]: P(materialises) 45%. Adversary suggested 50% for under 500 enrolled and 25% for a story. I rate the composite at 45% because a launch during the listing month is itself uncertain. If it does launch, low enrolment through a non-unionised channel is likely, but a follow-up story that gets noticed is less so.
</threat_odds>
